Prapa, Malvina http://orcid.org/0000-0002-6305-0350
Chiavelli, Chiara
Golinelli, Giulia http://orcid.org/0000-0003-2494-3778
Grisendi, Giulia
Bestagno, Marco http://orcid.org/0000-0002-8486-7511
Di Tinco, Rosanna
Dall’Ora, Massimiliano
Neri, Giovanni http://orcid.org/0000-0002-2035-8988
Candini, Olivia
Spano, Carlotta
Petrachi, Tiziana
Bertoni, Laura
Carnevale, Gianluca
Pugliese, Giuseppe
Depenni, Roberta
Feletti, Alberto
Iaccarino, Corrado
Pavesi, Giacomo
Dominici, Massimo http://orcid.org/0000-0002-4007-1503
Funding for this research was provided by:
This work was supported in part by: Project “Dipartimenti Eccellenti MIUR 2017” and the Associazione ASEOP
Article History
Received: 14 January 2021
Accepted: 22 September 2021
First Online: 27 October 2021
Competing interests
: G. Grisendi, C.S., and M. Dominici hold patents in the field of cancer and gene therapy and declare a consultancy role, research funding, and stock ownership with Rigenerand Srl. The remaining authors declare no competing interests. C.I. holds post-market surveillance counseling for Finceramica S.p.A.